THERMO FISHER SCIENTIFIC CELL, GENE AND ADVANCE THERAPIES
Thermo Fisher Scientific is a leading supplier for the cell and gene therapy development community, offering the quality products, services, and support needed to advance your therapeutics from discovery to the clinic and beyond.
Our experienced cell and gene therapy professionals, technical support teams, and highly specialized field application scientific teams are available to answer your questions, provide detailed product and protocol consultation, and implement customization services.
BROCHURES AND SOLUTIONS
-
![Thermo CGT - lab]( "Accelerating Cell Therapy Development Through Collaboration")
Accelerating Cell Therapy Development Through CollaborationCollaborations can provide critical resources and support to navigate obstacles and help accelerate speed-to-market. Our partnership program to assists customers on their paths to clinical and commercial success.
-
![Thermo CGT - cell therapy lab]( "Cell Therapy: Streamline The Path From Discovery To Commercialization")
Cell Therapy: Streamline The Path From Discovery To CommercializationThermo Fisher Scientific provides the quality products, services, and support you need to advance your cell therapy from discovery to the clinic through to commercialization.
VIDEOS AND WEBINARS
How NK Cell Therapies Are Poised For Breakthroughs In Cancer
In this first segment of our Cell & Gene Live, Building the Future of Cancer Immunotherapy Through Allogeneic NK Cell Innovation, expert panelists, Raphael Ognar, President, CEO, and Co-Founder of NKILT Therapeutics and Tracy Ryan, Co-Founder and Chief Commun...
Scaling Allogeneic NK Cell Therapies
In this segment of Cell & Gene Live, Building the Future of Cancer Immunotherapy Through Allogeneic NK Cell Innovation, Tracy Ryan, Co-Founder and Chief Communications Officer of NKore BioTherapeutics, highlighted the allogeneic, off-the-shelf nature of their...
Why Prolonged, Potent NK Cells May Transform Cancer Therapy
In this segment of Cell & Gene Live, Building the Future of Cancer Immunotherapy Through Allogeneic NK Cell Innovation, Raphael Ognar, President, CEO, and Co-Founder of NKILT Therapeutics explained that his team’s technology enables NK cells to remain a...
Building The Future Of Cancer Immunotherapy Through Allogeneic NK Cell Innovation | Audience Q&A
In this segment of Cell & Gene Live, Building the Future of Cancer Immunotherapy Through Allogeneic NK Cell Innovation, Raphael Ognar, President, CEO, and Co-Founder of NKILT Therapeutics and Tracy Ryan, Co-Founder and Chief Communications Officer of NKore Bi...
NK-Specific Strategies To Unlock Full Therapeutic Power
In this segment of Cell & Gene Live, Building the Future of Cancer Immunotherapy Through Allogeneic NK Cell Innovation, expert panelists Raphael Ognar, President, CEO, and Co-Founder of NKILT Therapeutics and Tracy Ryan, Co-Founder and Chief Communications Of...
CONTACT INFORMATION
Thermo Fisher Scientific Cell And Gene Therapy
168 Third Avenue
Waltham, MA 02451
UNITED STATES
FEATURED INSIGHTS
-
![GettyImages-1396855014 NK Cell]( "Functional And Phenotypic Characterization Of Human NK Cells Post-Expansion")
A new method for expanding natural killer cells provides a way to generate a large quantity of potent cells for clinical applications. This approach maintains key cell functions and killing ability.
-
![GettyImages-1400335416 NK Cell]( "NK Cell Expansion Using Scale Up Bioreactors For Cell Therapy")
A feeder-free medium and closed processing system can expand and process primary human NK cells for clinical use, helping researchers overcome a key bottleneck in cell therapy manufacturing.
-
![GettyImages-1443975905 lab, analytics, technology]( "Automated Bioprocessing To Enhance CAR T Cell Therapy Manufacturing")
Automated bioprocessing can significantly improve CAR T cell manufacturing by reducing errors and enhancing scalability. Explore how this approach supports consistent, high-quality cell therapy production.
-
![Thermo CGT - dynabeads]( "Harnessing The Versatility Of Magnetic Beads In CAR T Cell Manufacturing")
Explore advanced magnetic bead-based methods for isolating T cells, enabling high efficiency, scalability, and viability in CAR T cell manufacturing while addressing challenges posed by diverse patient samples.
-
![Thermo Fisher]( "A Closed Solution For T Cell Isolation And Activation")
We outline the incorporation of magnetic bead separation technology into a cell processing platform designed specifically for cell therapy applications.
-
![Gene therapy data GettyImages-1054555460]( "An Innovative Approach Towards Standardizing Cell Therapy Manufacturing")
Learn more about modular, fit-for-purpose platforms designed specifically to meet the requirements of cell therapy manufacturing right now, and in the future.
E-BOOKS
-
![GettyImages-2196603030 lab, research, gene therapy]( "Optimizing Production And Purification In AAV-Based Gene Therapy Manufacturing Workflow")
Explore strategies for optimizing AAV gene therapy manufacturing. Discover solutions for scaling production, enhancing purification, and improving analytical methods to accelerate therapeutic development.
-
![GettyImages-1027139762-test-lab-testing]( "Gene Therapy Solutions: From Discovery To Commercialization")
Learn how advanced technologies and methodologies are driving progress in gene therapy, enabling safer and more effective treatments for rare and complex diseases.
-
![Gene DNA iStock-644074330]( "Cell Therapy: Optimizing The Vein-To-Vein Workflow")
Delve into the cell therapy workflow and experience the patient as a focal point throughout their journey. Explore how a GMP-compliant, semiautomated manufacturing platform can result in consistent, efficacious CAR T cell production.
-
![Cells iStock-999018482]( "Considerations For Cell Therapy Development, Manufacturing")
Whether you’re new to cell therapy manufacturing or expanding your existing knowledge base, this educational handbook provides the major considerations for successful cell therapy manufacturing.
-
![Ask The Experts GettyImages-656208018]( "Scale Up And Process Development: Ask The Experts")
In this eBook, a panel of key thought leaders share their perspectives on current obstacles and future developments in scale up and process development.
